NCT00165139View on ClinicalTrials.gov

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 1996

Primary Completion Date

November 30, 2000

Study Completion Date

February 28, 2009

Conditions
NeuroblastomaEwings SarcomaNon-rhabdomyosarcoma Soft Tissue Sarcoma
Interventions
DRUG

Vincristine

Described under detailed description

DRUG

Cyclophosphamide

Described under detailed description

DRUG

Adriamycin

Described under detailed description

DRUG

Etoposide (VP-16)

Described under detailed description

DRUG

Cisplatin

Described under detailed description

DRUG

Carboplatin

Described under detailed description

DRUG

Melphalan

Described under detailed description

DRUG

Ifosfamide

Described under detailed description

DRUG

G-CSF (granulocyte-colony stimulating factor)

Described under detailed description

DRUG

Mesna

Described under detailed description

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Boston Children's Hospital

OTHER

collaborator

Children's Hospital of Philadelphia

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00165139 - Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | Biotech Hunter | Biotech Hunter